Skip to content

Development and Validation of a Clinical Prediction Model for Medical Abortion Outcomes: A Study Involving Retrospective Model Development and Prospective Validation

Development and Validation of a Clinical Prediction Model for Medical Abortion Outcomes: A Study Involving Retrospective Model Development and Prospective Validation

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500114798
Enrollment
Unknown
Registered
2025-12-17
Start date
2026-01-01
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

medical abortion

Interventions

Failed Medical Abortion Group:None
Successful Medical Abortion Group:None

Sponsors

The First Affiliated Hospital of Zhejiang Chinese Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1: Female patients aged 18 to 45 years; 2: Confirmed intrauterine pregnancy by ultrasonography, with a gestational age of <= 63 days (calculated from the first day of the last menstrual period); 3: Decision to undergo medical abortion using the mifepristone and misoprostol regimen; 4: No contraindications to the use of mifepristone or misoprostol; 5: Ability and willingness to comply with the follow-up procedures outlined in the study protocol; 6: Understanding of the study purpose and voluntary provision of informed consent.

Exclusion criteria

Exclusion criteria: 1: Suspected or confirmed ectopic pregnancy or molar pregnancy; 2: Presence of any known contraindication to medical abortion (e.g., chronic adrenal failure, long-term corticosteroid therapy, glaucoma, severe asthma, bleeding disorders, or known allergy to the drugs used); 3: Coexisting severe systemic disease (e.g., cardiac, hepatic, or renal insufficiency); 4: Inability to adhere to the scheduled follow-up visits or lack of reliable contact information; 5: Concurrent participation in any other clinical trial.

Design outcomes

Primary

MeasureTime frame
Complete abortion;

Secondary

MeasureTime frame
Imcomplete abortion;Persistent pregnancy;

Countries

China

Contacts

Public ContactHu Yunyun

The First Affiliated Hospital of Zhejiang Chinese Medical University

fuddyhu@163.com+86 571 8600 8571

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026